Literature DB >> 25577755

Prognostic value of serum galectin-3 in patients with heart failure: a meta-analysis.

Ao Chen1, Wolin Hou2, Yunhe Zhang1, Yingmin Chen3, Ben He1.   

Abstract

Entities:  

Keywords:  Adverse outcomes; All-cause mortality; Galectin-3; Heart failure; Meta-analysis

Mesh：

Substances：

Year:  2014        PMID： 25577755     DOI： 10.1016/j.ijcard.2014.12.137

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  26 in total

1.  Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes.

Authors:  Anahita Ghorbani; Vijeta Bhambhani; Robert H Christenson; Wouter C Meijers; Rudolf A de Boer; Daniel Levy; Martin G Larson; Jennifer E Ho
Journal:  J Am Coll Cardiol       Date:  2018-12-25       Impact factor: 24.094

Review 2.  Circulating galectin-3 on admission and prognosis in acute heart failure patients: a meta-analysis.

Authors:  Hongsen Chen; Chensong Chen; Junjie Fang; Ren Wang; Wanshui Nie
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

3.  Serial galectin-3 and future cardiovascular disease in the general population.

Authors:  A Rogier van der Velde; Wouter C Meijers; Jennifer E Ho; Frank P Brouwers; Michiel Rienstra; Stephan J L Bakker; Anneke C Muller Kobold; Dirk J van Veldhuisen; Wiek H van Gilst; Pim van der Harst; Rudolf A de Boer
Journal:  Heart       Date:  2016-04-15       Impact factor: 5.994

4.  Relationship between novel inflammatory biomarker galectin-3 and depression symptom severity in a large community-based sample.

Authors:  Darlene R King; Damilola C Salako; Samia Kate Arthur-Bentil; Arielle E Rubin; Jay B Italiya; Jenny S Tan; Dimitri G Macris; Hunter K Neely; Jayme M Palka; Justin L Grodin; Kaylee Davis-Bordovsky; Matthew Faubion; Carol S North; E Sherwood Brown
Journal:  J Affect Disord       Date:  2020-12-15       Impact factor: 4.839

5.  Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure.

Authors:  Laura C van Vark; Ivonne Lesman-Leegte; Sara J Baart; Douwe Postmus; Yigal M Pinto; Rudolf A de Boer; Folkert W Asselbergs; Elly M C J Wajon; Joke G Orsel; Eric Boersma; Hans L Hillege; K Martijn Akkerhuis
Journal:  J Am Heart Assoc       Date:  2017-11-29       Impact factor: 5.501

Review 6.  Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).

Authors:  Rui Dong; Min Zhang; Qunying Hu; Shan Zheng; Andrew Soh; Yijie Zheng; Hui Yuan
Journal:  Int J Mol Med       Date:  2017-12-05       Impact factor: 4.101

7.  A Multiparametric Approach Based on NT-proBNP, ST2, and Galectin3 for Stratifying One Year Prognosis of Chronic Heart Failure Outpatients.

Authors:  Dario Grande; Marta Leone; Caterina Rizzo; Paola Terlizzese; Giuseppe Parisi; Margherita Ilaria Gioia; Tiziana Leopizzi; Antonio Segreto; Piero Guida; Roberta Romito; Marco Matteo Ciccone; Francesca Di Serio; Massimo Iacoviello
Journal:  J Cardiovasc Dev Dis       Date:  2017-07-15

8.  ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure.

Authors:  Nadia Aspromonte; Michele Massimo Gulizia; Aldo Clerico; Giuseppe Di Tano; Michele Emdin; Mauro Feola; Massimo Iacoviello; Roberto Latini; Andrea Mortara; Roberto Valle; Gianfranco Misuraca; Claudio Passino; Serge Masson; Alberto Aimo; Marcello Ciaccio; Marco Migliardi
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

9.  ST2 and Galectin-3: Ready for Prime Time?

Authors:  Wouter C Meijers; A Rogier van der Velde; Rudolf A de Boer
Journal:  EJIFCC       Date:  2016-08-01

10.  Oxidative Stress in Metabolic Disorders: Pathogenesis, Prevention, and Therapeutics.

Authors:  Umesh C S Yadav; Vibha Rani; Gagan Deep; Rakesh K Singh; Komaraiah Palle
Journal:  Oxid Med Cell Longev       Date:  2016-02-01       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.